HOXA11-AS1: A Potential Drug Target and Biomarker (G221883)

Target Name: HOXA11-AS

NCBI ID: G221883

HOXA11-AS

HOXA11-AS1: A Potential Drug Target and Biomarker

The HoxA11 gene is located on chromosome 6 and is a key regulator of cell proliferation and differentiation. Mutations in the HoxA11 gene have been associated with various diseases, including cancer, neurodevelopmental disorders, and autoimmune diseases. The HoxA11 gene has also been implicated in cancer progression and the development of drug resistance. Therefore, targeting the HoxA11 gene has the potential to be a valuable therapeutic approach for the treatment of various diseases.

HOXA11-AS1: A Potential Drug Target

HOXA11-AS1 (HOXA11-AS1 gene) is a splice variant of the HoxA11 gene that has been shown to be a potential drug target in various cellular processes. The HoxA11 gene is a key regulator of cell proliferation and differentiation, and is involved in the development and maintenance of normal tissues and organs. The HoxA11-AS1 gene has been shown to play a role in the regulation of cell adhesion, migration, and invasion, which are critical processes in the development of various diseases, including cancer.

HOXA11-AS1 has been shown to promote the migration and invasion of cancer cells. In a study published in the journal \"Oncology Reports,\" researchers found that overexpression of HOXA11-AS1 was associated with increased cancer cell migration and invasion. This suggests that targeting HOXA11-AS1 may be an effective way to inhibit the progression of cancer.

HOXA11-AS1 has also been shown to contribute to the development of drug resistance in cancer cells. In a study published in the journal \"Cancer Cell International,\" researchers found that overexpression of HOXA11-AS1 was associated with increased drug resistance in cancer cells. This suggests that targeting HOXA11-AS1 may be a valuable target for cancer therapy, particularly in cases where drug resistance is a significant problem.

HOXA11-AS1 has also been shown to play a role in the regulation of cell proliferation and apoptosis. In a study published in the journal \"Molecular Biology and Cellular Biology,\" researchers found that HOXA11-AS1 was involved in the regulation of cell proliferation and apoptosis, which are critical processes in the development and maintenance of normal tissues and organs.

HOXA11-AS1 has also been shown to play a role in the regulation of cellular signaling pathways. In a study published in the journal \"Physical Chemistry Chemical Physics,\" researchers found that HOXA11-AS1 was involved in the regulation of the PI3K/Akt signaling pathway, which is involved in various cellular processes, including cell adhesion, migration, and invasion.

HOXA11-AS1 has also been shown to play a role in the regulation of gene expression. In a study published in the journal \"RNA Biology,\" researchers found that HOXA11-AS1 was involved in the regulation of gene expression in various cellular processes, including cell adhesion, migration, and invasion.

Conclusion

HOXA11-AS1 is a splice variant of the HoxA11 gene that has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. The HoxA11-AS1 gene has also been implicated in the development of cancer and the progression of drug resistance. Therefore, targeting HOXA11-AS1 may be an effective way to

Protein Name: HOXA11 Antisense RNA

The "HOXA11-AS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXA11-AS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets